Ariad Pharma (ARIA) Misses Q1 Loss Views by 3c
Tweet
Share
E-mailGet Alerts ARIA Hot Sheet
Price: $25.14 --0%
Financial Fact:
Income (loss) from operations: -24.99M
Today's EPS Names:
FWDI, GO, BATL, More
Financial Fact:
Income (loss) from operations: -24.99M
Today's EPS Names:
FWDI, GO, BATL, More
Join SI Premium – FREE
Ariad Pharma (NASDAQ: ARIA) reported Q1 EPS of ($0.29), $0.03 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $81 thousand versus the consensus estimate of $300 thousand.
For earnings history and earnings-related data on Ariad Pharma (ARIA) click here.
For earnings history and earnings-related data on Ariad Pharma (ARIA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Okta upgraded as AI security opportunity boosts outlook
- Home Depot CEO takes medical leave 6 days before Q2 earnings
- Abercrombie & Fitch (ANF) PT Raised to $153 at UBS on Decent Q2, Stable Trend Across Brands
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
